4

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: February 27, 2019
Period of Report: February 22, 2019
Accession Number: 0001645470-19-000015

View Document ↗ View on SEC.gov ↗